19198-Leukemia-CLL-1269

Leukemia

An Open Label Compassionate Use Trial of Ublituximab and/or Umbralisib (TGR-1202) in Combination with other Novel Agents or as Single Agents in Subjects Currently Receiving Treatment on a TG Therapeutics Study (UTX-TGR-501)

  • Details

ClinicalTrials.gov ID: NCT03207256
Diagnosis Type: CLL
USOR Number:

  • Address

11850 Blackfoot St NW, Suite 100
Coon Rapids, MN 55433
P: (763) 712-2100

Search by practice name, trial titles, indicators and specific disease types.